News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,297 Results
Type
Article (43575)
Company Profile (322)
Press Release (694390)
Multimedia
Podcasts (111)
Webinars (19)
Section
Business (210887)
Career Advice (2103)
Deals (36730)
Drug Delivery (118)
Drug Development (83352)
Employer Resources (176)
FDA (16786)
Job Trends (15485)
News (357130)
Policy (34101)
Tag
Academia (2602)
Accelerated approval (28)
Adcomms (25)
Allergies (131)
Alliances (51583)
ALS (166)
Alzheimer's disease (1649)
Antibody-drug conjugate (ADC) (286)
Approvals (17005)
Artificial intelligence (479)
Autoimmune disease (121)
Automation (33)
Bankruptcy (372)
Best Places to Work (11772)
BIOSECURE Act (21)
Biosimilars (184)
Biotechnology (190)
Bladder cancer (147)
Brain cancer (56)
Breast cancer (603)
Cancer (4528)
Cardiovascular disease (382)
Career advice (1779)
Career pathing (35)
CAR-T (269)
CDC (47)
Celiac Disease (1)
Cell therapy (702)
Cervical cancer (35)
Clinical research (70688)
Collaboration (1534)
Company closure (4)
Compensation (1065)
Complete response letters (54)
COVID-19 (2771)
CRISPR (88)
C-suite (715)
Cystic fibrosis (141)
Data (5807)
Decentralized trials (2)
Denatured (36)
Depression (115)
Diabetes (468)
Diagnostics (6695)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (227)
Drug pricing (185)
Drug shortages (31)
Duchenne muscular dystrophy (215)
Earnings (91469)
Editorial (53)
Employer branding (21)
Employer resources (154)
Events (119567)
Executive appointments (963)
FDA (19634)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1353)
Gene editing (189)
Generative AI (40)
Gene therapy (564)
GLP-1 (968)
Government (4773)
Grass and pollen (7)
Guidances (377)
Healthcare (19043)
HIV (49)
Huntington's disease (40)
IgA nephropathy (77)
Immunology and inflammation (241)
Immuno-oncology (40)
Indications (79)
Infectious disease (3016)
Inflammatory bowel disease (185)
Inflation Reduction Act (13)
Influenza (104)
Intellectual property (221)
Interviews (326)
IPO (16902)
IRA (55)
Job creations (4067)
Job search strategy (1497)
Kidney cancer (15)
Labor market (79)
Layoffs (571)
Leadership (31)
Legal (8416)
Liver cancer (90)
Longevity (13)
Lung cancer (619)
Lymphoma (359)
Machine learning (38)
Management (60)
Manufacturing (714)
MASH (159)
Medical device (13779)
Medtech (13817)
Mergers & acquisitions (20809)
Metabolic disorders (1187)
Multiple sclerosis (144)
NASH (17)
Neurodegenerative disease (286)
Neuropsychiatric disorders (73)
Neuroscience (2777)
NextGen: Class of 2025 (6643)
Non-profit (4549)
Now hiring (61)
Obesity (553)
Opinion (274)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (202)
Parkinson's disease (259)
Partnered (32)
Patents (459)
Patient recruitment (417)
Peanut (57)
People (60577)
Pharmaceutical (91)
Pharmacy benefit managers (28)
Phase I (21932)
Phase II (31073)
Phase III (23318)
Pipeline (4025)
Policy (278)
Postmarket research (2655)
Preclinical (9354)
Press Release (68)
Prostate cancer (219)
Psychedelics (45)
Radiopharmaceuticals (273)
Rare diseases (756)
Real estate (6300)
Recruiting (71)
Regulatory (24926)
Reports (51)
Research institute (2424)
Resumes & cover letters (360)
Rett syndrome (23)
RNA editing (13)
RSV (73)
Schizophrenia (146)
Series A (226)
Series B (170)
Service/supplier (12)
Sickle cell disease (95)
Special edition (23)
Spinal muscular atrophy (156)
Sponsored (41)
Startups (3759)
State (2)
Stomach cancer (17)
Supply chain (101)
Tariffs (92)
The Weekly (73)
Vaccines (980)
Venture capital (77)
Weight loss (368)
Women's health (74)
Worklife (17)
Date
Today (50)
Last 7 days (212)
Last 30 days (1986)
Last 365 days (30694)
2025 (30630)
2024 (35772)
2023 (40630)
2022 (51798)
2021 (56329)
2020 (54791)
2019 (47399)
2018 (35770)
2017 (33136)
2016 (32663)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (798)
Alabama (77)
Alaska (7)
Arizona (298)
Arkansas (14)
Asia (41927)
Australia (6706)
California (10527)
Canada (3128)
China (1030)
Colorado (442)
Connecticut (450)
Delaware (315)
Europe (89823)
Florida (1560)
Georgia (334)
Hawaii (2)
Idaho (61)
Illinois (809)
India (57)
Indiana (504)
Iowa (20)
Japan (394)
Kansas (122)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1322)
Massachusetts (7645)
Michigan (305)
Minnesota (596)
Mississippi (5)
Missouri (121)
Montana (30)
Nebraska (27)
Nevada (113)
New Hampshire (73)
New Jersey (2851)
New Mexico (29)
New York (2811)
North Carolina (1386)
North Dakota (8)
Northern California (5053)
Ohio (309)
Oklahoma (21)
Oregon (43)
Pennsylvania (2163)
Puerto Rico (19)
Rhode Island (45)
South America (1166)
South Carolina (60)
South Dakota (1)
Southern California (4077)
Tennessee (164)
Texas (1633)
United States (37773)
Utah (314)
Vermont (1)
Virginia (257)
Washington D.C. (78)
Washington State (870)
West Virginia (4)
Wisconsin (95)
Wyoming (2)
738,297 Results for "rigel pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
·
1 min read
Press Releases
Rigel to Present at the 2025 Jefferies Global Healthcare Conference in London
November 13, 2025
·
1 min read
Press Releases
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
November 4, 2025
·
16 min read
Press Releases
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
October 30, 2025
·
1 min read
Press Releases
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
December 8, 2025
·
7 min read
Press Releases
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
November 18, 2025
·
13 min read
Press Releases
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
November 3, 2025
·
18 min read
Biotech Bay
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
Rigel Pharmaceuticals, Inc. (“Rigel”) (Nasdaq: RIGL) today announced the completion of the transfer to Rigel of the New Drug Application (NDA) for GAVRETO®.
June 24, 2024
·
10 min read
Press Releases
Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
October 9, 2025
·
5 min read
Press Releases
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
August 6, 2025
·
17 min read
1 of 73,830
Next
